logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Former Federal Reserve Governor Warsh: If the vote supports a rate cut next week, the leadership of the Fed needs to be replaced.

date
26/07/2025
Former Fed Governor Wash said that if he were to vote, he would support a rate cut next week. When asked if he wanted to be the Fed Chairman, he said, "If the President called, I would be very honored." Wash said that there is no need for new laws, what is needed is a change in Fed leadership. He also stated that it is necessary to show the market that we are serious about cutting expenses.
Latest
4 m ago
French electricity group: Flamanville 1 reactor with an installed capacity of 1330 megawatts was shut down at 15:52 local time on July 22 for unplanned maintenance, and is expected to resume operation at 03:30 on July 26 local time.
5 m ago
An earthquake has occurred in the Alxa Left Banner of Inner Mongolia, but no reports of casualties or injuries have been received yet.
9 m ago
The 2025 World Artificial Intelligence Conference opens today with over a hundred first launch debuts. The scale is the largest in history.
13 m ago
Sarepta Therapeutics issues clarification: The death of an 8-year-old child is unrelated to the company's gene therapy Elevidys. The incident was reported to the US Food and Drug Administration on June 18th.
14 m ago
The mid-year dividend payment plan of A-share listed companies is expected to double year-on-year, paving the way for a healthy development cycle.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.